| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10908640 | Leukemia Research | 2015 | 7 Pages |
Abstract
MFIR has value in predicting outcomes including DFS and OS as well as induction failure. This is particularly true for patients with intermediate risk cytogenetics and when combined with assessment for the FLT3-ITD mutation.
Keywords
AMLHiDACInduction failureROCATP binding cassette transportersDFSMRCCEBPABcrpNPM1DNRallo-SCTMitoxantroneMDR1Disease free survivaloverall survivalPeripheral bloodDaunorubicincomplete remissionMedical Research Councilacute myeloid leukemiabone marrownucleophosminreceiver operating characteristicsCCAAT/enhancer binding protein alphabreast cancer resistance proteinmultidrug resistance protein 1prognosisAllogeneic stem cell transplantation
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
XiaoYu Yuan, Joshua Koehn, Donna E. Hogge,